News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Pharm Country
Stem Cell Treatments in the News: NeoStem, Inc. Featured on CBS’s Eye on New York
July 22, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK, July 22 /PRNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS) today announced that the Company was featured on CBS's Eye on New York City on Sunday morning July 19, 2009.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
Alzheimer’s disease
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s
November 18, 2026
·
6 min read
·
Heather McKenzie
Alzheimer’s disease
CTAD 2026: AriBio’s Alzheimer’s candidate slows cognitive decline as monotherapy
November 17, 2026
·
3 min read
·
Nick Paul Taylor
Alzheimer’s disease
Alzheimer’s field looks beyond amyloid as biopharma converges at CTAD 2026
November 16, 2026
·
7 min read
·
Nick Paul Taylor
GLP-1
Altimmune gears up for FDA meeting on pivotal Phase 3 trial in alcohol use disorder
November 10, 2026
·
2 min read
·
Nick Paul Taylor